sunitinib or pazopanib
MRCC-China collaboration
Unknown small_molecule active
Quick answer
sunitinib or pazopanib for Metastatic Renal Cell Carcinoma is a Unknown program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Metastatic Renal Cell Carcinoma
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active